November 2019 - Insight, China's Pharmaceutical Industry

Monday, 14 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Home
About US
Policy Hub
Categories
- Drug
- Company
- Deals
- Policy / Regulatory
- Medical Device
- R&D
- Legal / IP
- Digital
Privacy Policy
Contact US

Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1

Read History

Search

Pages
- Home
- Blog Index
- POLICY HUB
- Contact Us
Personalized
- Read History
Categories
- Company
- Drug
- Policy / Regulatory
- Medical Device
- R&D
- Digital
- Legal / IP
- Deals

Have an existing account? Sign In

Follow US

Hanx Biopharmaceuticals’ HX009 Receives NMPA Clinical Trial Approval for PD-1/CD47 Bispecific Antibody

November 25, 2024

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

Contact Us
Advertise with US
Complaint
Our Team
Our Values
Privacy Policy

Subscribe Now for Real-time Updates on the Latest Stories!

I have read and agree to the terms & conditions

Leave this field empty if you're human:

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry. All Rights Reserved.

Welcome to Fineline Cube!

Username or Email Address

Password

Remember me

Lost your password?

Not a member? Sign Up